cleardata.comHealthcare / Healthcare softwareFounded: 2009Funding to Date: $160.84MM
ClearDATA is the developer of a healthcare-focused, HITRUST-certified cloud designed to safeguard clients' sensitive data and power their critical applications available across the major public cloud platforms.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
11/19/2018 | Series E | $26MM | $xx.xx | $220.91MM | Excel Venture Management, Flare Capital Partners, Hcsc Ventures, Heritage Group, Hlm Venture Partners, Merck Global Health Innovation Fund | |
Price per Share
$xx.xx
Shares Outstanding
33,893,886
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Excel Venture Management, Flare Capital Partners, Hcsc Ventures, Heritage Group, Hlm Venture Partners, Merck Global Health Innovation Fund
|
||||||
04/18/2017 | Series D | $12MM | $xx.xx | $161.01MM | Excel Venture Management, Flare Capital Partners, Heritage Group, Hlm Venture Partners, Merck Global Health Innovation Fund, Norwest Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
18,507,097
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Excel Venture Management, Flare Capital Partners, Heritage Group, Hlm Venture Partners, Merck Global Health Innovation Fund, Norwest Venture Partners
|
||||||
05/28/2015 | Series C | $25MM | $xx.xx | $86.47MM | Excel Venture Management, Flare Capital Partners, Heritage Group, Hlm Venture Partners, Merck Global Health Innovation Fund, Norwest Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
69,079,855
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Excel Venture Management, Flare Capital Partners, Heritage Group, Hlm Venture Partners, Merck Global Health Innovation Fund, Norwest Venture Partners
|
||||||
07/22/2013 | Series B | $14MM | $xx.xx | $33.19MM | Excel Venture Management, Norwest Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
60,632,307
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Excel Venture Management, Norwest Venture Partners
|
||||||
03/14/2012 | Series A | $3.42MM | $xx.xx | $8.54MM | Arena Capital Partners, Norwest Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
25,601,608
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Arena Capital Partners, Norwest Venture Partners
|